CAPZA2 expression based on
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison | Statistical significance |
Normal-vs-Primary | <1E-12 |
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
2.57389998203905E-10 |
Normal-vs-Stage2 |
4.07380000000401E-05 |
Normal-vs-Stage3 |
N/A |
Normal-vs-Stage4 |
1.165550E-04 |
Stage1-vs-Stage2 |
2.612200E-01 |
Stage1-vs-Stage3 |
N/A |
Stage1-vs-Stage4 |
9.969800E-01 |
Stage2-vs-Stage3 |
N/A |
Stage2-vs-Stage4 |
2.885600E-01 |
Stage3-vs-Stage4 |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.62592161956354E-12 |
Normal-vs-AfricanAmerican |
2.145400E-01 |
Normal-vs-Asian |
1.751750E-02 |
Caucasian-vs-AfricanAmerican |
1.223010E-01 |
Caucasian-vs-Asian |
5.866200E-01 |
AfricanAmerican-vs-Asian |
2.378800E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.11059994534202E-09 |
Normal-vs-Female |
8.72329986023601E-10 |
Male-vs-Female |
1.441000E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient BMI information is not available for 1 sample.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
1.036390E-04 |
Normal-vs-Extreme_Weight |
2.81040002381161E-09 |
Normal-vs-Obese |
5.152500E-04 |
Normal-vs-Extreme_Obese |
N/A |
Normal_Weight-vs-Extreme_Weight |
5.138400E-01 |
Normal_Weight-vs-Obese |
4.288000E-01 |
Normal_Weight-vs-Extreme_Obese |
N/A |
Extreme_Weight-vs-Obese |
6.923000E-01 |
Extreme_Weight-vs-Extreme_Obese |
N/A |
Obese-vs-Extreme_Obese |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
7.322300E-02 |
Normal-vs-Age(41-60Yrs) |
3.63290000304772E-08 |
Normal-vs-Age(61-80Yrs) |
4.48939996289255E-09 |
Normal-vs-Age(81-100Yrs) |
2.593400E-01 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.008600E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.825200E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.962600E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.463160E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.825160E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.421200E-01 |
|
|
CHOL : Cholangiocarcinoma
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
N/A |
Normal-vs-Grade 2 |
1.930970E-01 |
Normal-vs-Grade 3 |
1.248600E-01 |
Normal-vs-Grade 4 |
1.000000E+00 |
Grade 1-vs-Grade 2 |
N/A |
Grade 1-vs-Grade 3 |
N/A |
Grade 1-vs-Grade 4 |
N/A |
Grade 2-vs-Grade 3 |
8.127800E-01 |
Grade 2-vs-Grade 4 |
1.930970E-01 |
Grade 3-vs-Grade 4 |
1.248600E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 5 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
9.81259518084698E-12 |
Normal-vs-N1 |
1.937350E-03 |
N0-vs-N1 |
4.624800E-01 |
|
|